399441 生物医药
交易中 10-08 13:04:21
资讯
新帖
简况
纳指创收盘新高、英伟达逼近 6 万亿美元，但昨夜最极端的行情在生物医药
链捕手 · 10-07 18:27
纳指创收盘新高、英伟达逼近 6 万亿美元，但昨夜最极端的行情在生物医药
港股生物医药股开盘下挫，金斯瑞生物跌超15%
新浪港股 · 10-07 09:42
港股生物医药股开盘下挫，金斯瑞生物跌超15%
生物医药板块大幅回调 恒生生物科技指数跌3.15%
金吾财讯 · 10-07 09:35
生物医药板块大幅回调 恒生生物科技指数跌3.15%
生物医药板块走高 恒生生物科技指数涨2.32% 金斯瑞生物科技（01548）涨5.30%
金吾财讯 · 10-06 10:01
生物医药板块走高 恒生生物科技指数涨2.32% 金斯瑞生物科技（01548）涨5.30%
生物医药板块局部活跃 金斯瑞生物科技（01548）涨4.67%、百济神州（06160）涨2.92%
金吾财讯 · 10-05 14:10
生物医药板块局部活跃 金斯瑞生物科技（01548）涨4.67%、百济神州（06160）涨2.92%
9月30日沃森生物涨5.49%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 09-30
9月30日沃森生物涨5.49%，招商国证生物医药指数(LOF)C基金重仓该股
宜明昂科-B(01541)附属宜明凯尔生物医药技术(上海)完成增资
智通财经 · 09-28
宜明昂科-B(01541)附属宜明凯尔生物医药技术(上海)完成增资
派格生物医药-B盘中跌超5%
同花顺 · 09-28
派格生物医药-B盘中跌超5%
模型公司入局生物医药：2026，AI制药迎来关键之年
澎湃新闻 · 09-28
模型公司入局生物医药：2026，AI制药迎来关键之年
港股生物医药概念股走高，金斯瑞生物科技涨超9%
每日经济新闻 · 09-25
港股生物医药概念股走高，金斯瑞生物科技涨超9%
9月24日美迪西生物医药跌7.83%，广发医疗保健股票A基金重仓该股
证券之星 · 09-24
9月24日美迪西生物医药跌7.83%，广发医疗保健股票A基金重仓该股
生物医药板块全线走低 诺诚健华（09969）跌10.48% 机构指行业需求尚未明显回暖
金吾财讯 · 09-24
生物医药板块全线走低 诺诚健华（09969）跌10.48% 机构指行业需求尚未明显回暖
公司问答丨力生制药：生物医药项目投资回报周期较长 收益兑现时点存在不确定性
格隆汇 · 09-23
公司问答丨力生制药：生物医药项目投资回报周期较长 收益兑现时点存在不确定性
9月23日美迪西生物医药涨6.57%，广发医疗保健股票A基金重仓该股
证券之星 · 09-23
9月23日美迪西生物医药涨6.57%，广发医疗保健股票A基金重仓该股
9月23日甘李药业涨5.47%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 09-23
9月23日甘李药业涨5.47%，招商国证生物医药指数(LOF)C基金重仓该股
东富龙：坚持"专业技术服务于生物医药"
证券之星 · 09-23
东富龙：坚持"专业技术服务于生物医药"
尾盘异动！港股全线上涨，生物医药大爆发
同花顺 · 09-21
尾盘异动！港股全线上涨，生物医药大爆发
生物医药板块盘初普升 复宏汉霖（02696）涨7.96% 机构指中国创新药进入全球价值兑现阶段
金吾财讯 · 09-21
生物医药板块盘初普升 复宏汉霖（02696）涨7.96% 机构指中国创新药进入全球价值兑现阶段
全球生物医药版图上演“上海跃迁”：从单品爆款到能力出海 剑指原创始发地
上观新闻 · 09-21
全球生物医药版图上演“上海跃迁”：从单品爆款到能力出海 剑指原创始发地
每周股票复盘：博瑞生物医药（688166）股东减持547.33万股致股本变动
证券之星 · 09-20
每周股票复盘：博瑞生物医药（688166）股东减持547.33万股致股本变动
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":2211.71,"timestamp":1791435861000,"preClose":2254.74,"halted":0,"volume":541107881,"delay":0,"changeRate":-0.0191,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-43.03,"latestTime":"10-08 13:04:21","open":2270.71,"high":2271.45,"low":2211.71,"amount":18623000000,"amplitude":0.0265,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791442800000},"marketStatusCode":2,"adr":0,"adjPreClose":2254.74,"symbolType":"index","openAndCloseTimeList":[[1791423000000,1791430200000],[1791435600000,1791442800000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441","defaultTab":"news","newsList":[{"id":"2673092946","title":"纳指创收盘新高、英伟达逼近 6 万亿美元，但昨夜最极端的行情在生物医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2673092946","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673092946?lang=zh_cn&edition=full","pubTime":"2026-10-07 18:27","pubTimestamp":1791368836,"startTime":"0","endTime":"0","summary":" 标普500十一大板块十涨一跌，材料（+1.22%）与通信服务（+1.14%）领涨。但真正极端的行情出现在生物医药。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2294657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQ","MNQmain","QQQA","SPTE","VGT","TTEQ","NVDA","SQQQ","LFGY","QQQM","XBI","USD","QLD","TRFK","QQQI","GAMR","161726","AIFD","399441","ABFL","NVIW.SI","QID","IYW","AGOX","QQQE","TYLG","ROM","NQmain","QYLG","TQQY","SHOC","ILDR","09388","TTXU","METV","QQQY","AIPI","VT","03086","ONEQ","PSQ","09788","QQQJ","FAI","159659","SNVDAmain","IXN",".IXIC","TQQQ"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2673626064","title":"港股生物医药股开盘下挫，金斯瑞生物跌超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673626064","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673626064?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:42","pubTimestamp":1791337320,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端10月7日消息，港股生物医药股开盘下挫，金斯瑞生物跌超15%，再鼎医药跌超7%，泰格医药、君实生物跌超6%，荣昌生物、诺诚健华跌超4%。渤海证券指出，近期AI制药催化密集，行业焦点逐步从模型能力转向湿实验验证效率等方面，建议关注AI制药相关基因合成、蛋白表达、试剂耗材、动物模型及临床试验等细分赛道的投资机遇。同时，2026年ESMO年会即将召开，优异临床数据有望读出，带来板块密集催化，建议关注创新药、CXO及生命科学上游产业链等的投资机遇。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-10-07/doc-iniukhki8273392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","399441","161726","VXUS","BK4585","BK4588","KCAI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673064659","title":"生物医药板块大幅回调 恒生生物科技指数跌3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673064659","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673064659?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:35","pubTimestamp":1791336927,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块大幅回调，截至发稿，恒生生物科技指数跌3.15%，恒生医疗保健指数跌2.73%，万得港股中国创新药指数跌2.39%。个股方面，金斯瑞生物科技（01548）跌14.81%，再鼎医药（09688）跌4.47%，药明合联（02268）跌3.68%，药明生物（02269）跌2.50%，百济神州（06160）跌1.18%，诺诚健华（09969）跌1.43%，康诺亚-B（02162）跌1.32%，康方生物（09926）跌1.45%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993174","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","BK4588","LU0228659784.USD","LU0320764243.SGD","LU0456846285.SGD","LU3063872942.SGD","KURE","LU1720050803.USD","LU0348825331.USD","LU2488822045.USD","LU0572944931.SGD","XBI","161726","LU0417516738.SGD","02269","LU0828237510.HKD","LU1242518931.SGD","LU1242518857.USD","LU1794554557.SGD","LU0359202008.SGD","LU0561508036.HKD","09926","01548","IE00B543WZ88.USD","IE00B0JY6N72.USD","LU0348784397.USD","LU0320764599.SGD","LU2039709279.SGD","LU0244354667.USD","LU0588546209.SGD","BK1574","09969","SG9999002562.SGD","LU1880383366.USD","LU0516423174.USD","399441","LU0348766576.USD","SG9999014674.SGD","BK1161","LU0856984785.SGD","09688","SG9999002463.SGD","BK1521","LU0052750758.USD","02162","BK1141","LU0211977185.USD","06160","LU0456827905.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673033818","title":"生物医药板块走高 恒生生物科技指数涨2.32% 金斯瑞生物科技（01548）涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673033818","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673033818?lang=zh_cn&edition=full","pubTime":"2026-10-06 10:01","pubTimestamp":1791252073,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块走高，恒生生物科技指数涨2.32%，恒生医疗保健指数涨2.19%，万得中国创新药指数涨2.15%。个股方面，再鼎医药涨6.97%，金斯瑞生物科技涨5.30%，君实生物涨3.07%，药明生物涨3.07%，康方生物涨2.92%，康诺亚-B涨2.33%，泰格医药涨1.90%，诺诚健华涨1.87%。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993104","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","LU0181495838.USD","LU0708995583.HKD","LU0348784397.USD","09926","01877","LU0051755006.USD","LU0359202008.SGD","LU0456827905.SGD","LU1794554557.SGD","HK0000306701.USD","09969","BK1141","LU2039709279.SGD","LU0516423174.USD","LU0348735423.USD","LU2778985437.USD","BK4581","01548","BK1574","LU0052750758.USD","161726","LU0417516902.SGD","399441","LU2488822045.USD","LU0634319403.HKD","LU1720050803.USD","LU0128522744.USD","LU0327786744.USD","SG9999002562.SGD","BK1515","XBI","LU1242518857.USD","02162","02269","LU0039217434.USD","LU0320764599.SGD","SG9999002463.SGD","HK0000320223.HKD","LU0140636845.USD","LU0307460666.USD","LU1880383366.USD","KURE","LU0516422952.EUR","09688","LU0708995153.HKD","03347","IE00BPRC5H50.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673770524","title":"生物医药板块局部活跃 金斯瑞生物科技（01548）涨4.67%、百济神州（06160）涨2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673770524","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673770524?lang=zh_cn&edition=full","pubTime":"2026-10-05 14:10","pubTimestamp":1791180649,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块局部表现活跃，截至发稿，金斯瑞生物科技 涨4.67%，百济神州涨2.92%，药明生物涨1.65%，药明康德涨1.14%。消息面上，山西证券表示，AI模型公司以及众多MNC对AI高度重视已充分说明AI制药是未来AI应用的重要方向之一。短期看，通过AI模型设计的大量药物分子有望转化成上游服务企业的新增订单；中长期看，AI制药未来有望大幅提高药物研发效率和研发质量。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993064","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LU0456827905.SGD","LU1242518857.USD","161726","LU0348766576.USD","LU0417516902.SGD","LU2039709279.SGD","LU2778985437.USD","BK4585","LU1770034418.SGD","LU0561508036.HKD","02269","IE00B0JY6N72.USD","LU0307460666.USD","BK1610","LU0228659784.USD","LU2125910500.SGD","LU2045819591.USD","LU2476274720.SGD","399441","01548","BK4581","LU0819121731.USD","LU0540923850.HKD","LU0348767384.USD","HK0000306685.HKD","LU0708995583.HKD","LU0029874905.USD","XBI","688235","02359","LU0051755006.USD","LU0181495838.USD","ONC","06160","BK4526","LU0327786744.USD","LU0516422366.SGD","LU0211977185.USD","LU0320764243.SGD","LU0320764599.SGD","LU0516422440.USD","LU0572944931.SGD","LU0634319403.HKD","LU0039217434.USD","LU0828237510.HKD","BK4139","HK0000306701.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671274469","title":"9月30日沃森生物涨5.49%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671274469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671274469?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:38","pubTimestamp":1790757521,"startTime":"0","endTime":"0","summary":"证券之星消息，9月30日沃森生物涨5.49%，收盘报14.23元，换手率9.73%，成交量153.56万手，成交额21.83亿元。重仓沃森生物的前十大公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000026014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","399441","161726","BK0046","BK0239","300142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255434","title":"宜明昂科-B(01541)附属宜明凯尔生物医药技术(上海)完成增资","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255434","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670255434?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:40","pubTimestamp":1790606412,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B(01541)发布公告，内容有关附属宜明凯尔生物医药技术(上海)获增资5000万元。于本公告日期，增资及有关增资的相关工商登记程序已完成。投资者已根据增资协议完成支付人民币5000万元的对价。增资完成后，目标公司宜明凯尔生物医药技术(上海)有限公司分别由公司、嘉兴昶新、生科起航、新界创元及王先生持有约68.34%、15.83%、6.33%、6.33%及3.17%股权。因此，目标公司仍为公司非全资附属公司，且其财务业绩继续并入集团财务报表。目标公司主要从事开发代谢性疾病及罕见病创新药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XBI","BK4588","161726","01541","399441","BK4581","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670287662","title":"派格生物医药-B盘中跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670287662","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670287662?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:06","pubTimestamp":1790582760,"startTime":"0","endTime":"0","summary":"9月28日，派格生物医药-B(02565.HK)盘中跌超5%，截至16时3分，跌5.41%，报5.07港元/股，成交额1560.48万港元。 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260928/c680314705.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260928/c680314705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["399441","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402915","title":"模型公司入局生物医药：2026，AI制药迎来关键之年","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402915","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670402915?lang=zh_cn&edition=full","pubTime":"2026-09-28 07:28","pubTimestamp":1790551680,"startTime":"0","endTime":"0","summary":"伴随AI技术的快速迭代，AI制药似乎迎来了新的转机。科技巨头加快布局掌握高水平通用模型的头部AI模型公司在今年加强了在生物医药方面的布局。在生物医药研发的各个环节中，如何将AI筛选和设计的药物分子更高效地在实验室中进行验证，是AI应用的一大难题。模型公司入局生物医药，“推进干湿闭环，让模型‘长’出实体，可能会是行业颠覆。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-09-28/doc-initirzr3976058.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-28/doc-initirzr3976058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VTHR","161726","BK1191","BK1574","BK4581","BK4585","BK4588","CHAT","AIPO","AGIX","399441","01477","ARTY","XBI","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670544393","title":"港股生物医药概念股走高，金斯瑞生物科技涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670544393","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670544393?lang=zh_cn&edition=full","pubTime":"2026-09-25 14:23","pubTimestamp":1790317403,"startTime":"0","endTime":"0","summary":"港股生物医药概念股走高，金斯瑞生物科技涨超9%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609253884270486.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609253884270486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["161726","KCAI","VXUS","BK4581","HK0000306701.USD","HK0000320223.HKD","BK1141","BK4585","BK4588","399441","HK0000306685.HKD","BK1576","BK1583","01548","XBI","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480463","title":"9月24日美迪西生物医药跌7.83%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669480463?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:38","pubTimestamp":1790239085,"startTime":"0","endTime":"0","summary":"证券之星消息，9月24日美迪西生物医药跌7.83%，收盘报107.91元，换手率5.26%，成交量7.06万手，成交额7.89亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共27家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400028538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","161726","399441","688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669451177","title":"生物医药板块全线走低 诺诚健华（09969）跌10.48% 机构指行业需求尚未明显回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451177","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669451177?lang=zh_cn&edition=full","pubTime":"2026-09-24 13:36","pubTimestamp":1790228201,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块午后全线走低，截至发稿，诺诚健华 跌10.48%，荣昌生物跌7.99%，复宏汉霖跌7.68%，康诺亚-B跌5.86%，再鼎医药跌5.32%，君实生物跌4.53%，金斯瑞生物科技跌4.21%，康方生物跌3.54%，科伦博泰生物跌3.11%，泰格医药跌2.35%，药明生物跌1.80%，百济神州跌1.56%，药明合联跌1.12%。消息面上，国盛证券发布研报称，医药行业需求尚未明显回暖，降本增效、费用精细化管理已成为利润端的重要支撑。下半年关注流感旺季带来的阶段性需求催化。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992441","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","09926","LU3063872942.SGD","LU1303224171.USD","BK1576","LU0516422366.SGD","LU0561508036.HKD","01548","XBI","LU0348766576.USD","LU0828237510.HKD","LU0856984785.SGD","02269","BK4581","BK1515","KURE","SG9999002562.SGD","BK1141","09688","02162","LU2328871848.SGD","HK0000306701.USD","399441","LU0540923850.HKD","BK1583","01877","02696","09995","161726","LU0140636845.USD","03347","LU0456846285.SGD","09969","LU2399975544.HKD","SG9999002463.SGD","LU0348783233.USD","LU1961090484.USD","LU1770034418.SGD","06160","06990","688428","LU1880383366.USD","LU1719994722.HKD","LU1242518931.SGD","SG9999014674.SGD","LU1242518857.USD","02268","LU0348825331.USD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669092301","title":"公司问答丨力生制药：生物医药项目投资回报周期较长 收益兑现时点存在不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2669092301","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669092301?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:44","pubTimestamp":1790153099,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","002393","BK0188","BK0239","399441","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669010918","title":"9月23日美迪西生物医药涨6.57%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669010918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669010918?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:37","pubTimestamp":1790152659,"startTime":"0","endTime":"0","summary":"证券之星消息，9月23日美迪西生物医药涨6.57%创60日新高，收盘报117.08元，换手率5.84%，成交量7.84万手，成交额9.14亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共27家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","399441","BK0216","688202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669810916","title":"9月23日甘李药业涨5.47%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669810916","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669810916?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:36","pubTimestamp":1790152618,"startTime":"0","endTime":"0","summary":"证券之星消息，9月23日甘李药业涨5.47%，收盘报74.56元，换手率2.95%，成交量16.54万手，成交额12.12亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共31家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.39亿元，最新净值0.4118，较上一交易日下跌0.46%，近一年下跌9.49%。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","161726","399441","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669105209","title":"东富龙：坚持\"专业技术服务于生物医药\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2669105209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669105209?lang=zh_cn&edition=full","pubTime":"2026-09-23 15:42","pubTimestamp":1790149331,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙09月23日在投资者关系平台上答复投资者关心的问题。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300022240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","399441","161726","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669356154","title":"尾盘异动！港股全线上涨，生物医药大爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2669356154","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669356154?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:18","pubTimestamp":1789982280,"startTime":"0","endTime":"0","summary":"【导读】三大指数集体上涨，恒指重返25000点，生物医药板块大爆发9月21日，港股三大指数低开后震荡走高，午后升幅进一步扩大，最终集体收涨。截至发稿，恒生指数重返25000点之上，报25042.7 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260921/c680130705.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260921/c680130705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["KCAI","BK4581","161726","BK4588","BK4585","XBI","VXUS","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669136031","title":"生物医药板块盘初普升 复宏汉霖（02696）涨7.96% 机构指中国创新药进入全球价值兑现阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2669136031","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669136031?lang=zh_cn&edition=full","pubTime":"2026-09-21 09:49","pubTimestamp":1789955355,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普升，截至发稿，复宏汉霖 涨7.96%，诺诚健华涨7.34%，荣昌生物涨6.69%，康诺亚-B涨6.52%，康方生物涨6.46%，君实生物涨6.41%，金斯瑞生物科技涨5.80%，科伦博泰生物涨5.63%，药明生物涨4.47%，药明康德涨2.90%，泰格医药涨2.69%，百济神州涨2.07%，药明合联涨1.75%。中信证券表示，中国创新药进入全球价值兑现阶段，头部国际化创新药企业有望迎来产品全球价值兑现期。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250110/OTZhY2RjY2M0NGRhYmE3MDgxYTI5ZDA4OTNlODY4MjM3MDk5ODc3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/OTZhY2RjY2M0NGRhYmE3MDgxYTI5ZDA4OTNlODY4MjM3MDk5ODc3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992049","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0979878070.USD","LU0244354667.USD","LU0326950275.SGD","03347","LU0634319403.HKD","LU2476274720.SGD","02696","LU0456827905.SGD","LU1880383366.USD","BK1610","02359","LU0052750758.USD","LU0327786744.USD","LU0348784397.USD","LU0320764243.SGD","LU0348766576.USD","06990","BK4588","LU2242644610.SGD","09926","LU0128522744.USD","LU0196878994.USD","LU1303224171.USD","LU0320764599.SGD","KURE","02162","BK1515","02268","LU2488822045.USD","BK1588","06160","01548","LU0348767384.USD","XBI","399441","LU0561508036.HKD","LU2045819591.USD","161726","LU0029874905.USD","HK0000165453.HKD","LU1961090484.USD","01877","LU1188198961.HKD","09995","LU0463099449.HKD","09969","LU0540923850.HKD","02269","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669804521","title":"全球生物医药版图上演“上海跃迁”：从单品爆款到能力出海 剑指原创始发地","url":"https://stock-news.laohu8.com/highlight/detail?id=2669804521","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669804521?lang=zh_cn&edition=full","pubTime":"2026-09-21 06:15","pubTimestamp":1789942504,"startTime":"0","endTime":"0","summary":"上海在全球生物医药创新版图上的坐标，正在发生新一轮跃迁。过去20多年，伴随跨国药企研发中心集聚、本土创新企业成长，上海逐步融入全球药物研发体系。如今，一些新的变化正在发生，越来越多创新始于上海，与其一道汇入全球的不只是由一个个“单品爆款”串起的新药成果，还包括根植于本地创新生态的技术平台和能力体系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213879508726.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213879508726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4588","399441","161726","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668906916","title":"每周股票复盘：博瑞生物医药（688166）股东减持547.33万股致股本变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2668906916","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668906916?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:07","pubTimestamp":1789837632,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘，博瑞生物医药报收于35.03元，较上周的35.23元下跌0.57%。本周，博瑞生物医药9月18日盘中最高价报36.15元。博瑞生物医药当前最新总市值152.66亿元，在化学制药板块市值排名27/149，在两市A股市值排名1261/5220。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688166","161726","BK0239","399441"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791435863574,"stockEarnings":[{"period":"1week","weight":0.0061},{"period":"1month","weight":0.0416},{"period":"3month","weight":0.1084},{"period":"6month","weight":0.0363},{"period":"1year","weight":-0.1006},{"period":"ytd","weight":0.0507}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}